19 February 2018
News and Views
Links and Services
Proton pump inhibitor treatment is associated with the severity of liver disease and increased mortality in patients with cirrhosis, reports March's Alimentary Pharmacology & Therapeutics.
Proton pump inhibitors (PPI) are widely used in patients with liver diseases.
Within the l
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors